Tynixa
Digital Scientific Review Room

Every genomic case needs a scientific review room.

Tynixa makes that room digital, governed, evidence-aware, continuously monitored, and audit-ready.

It organizes variant identity, evidence, conflicts, missing evidence, safety boundaries, and human review routing into one review-ready workspace. It does not issue autonomous final diagnosis, final ACMG classification, treatment recommendation, or clinical release.

View safe sample room Request pilot briefing
Variant Identity

Canonical variant, aliases, transcript, build, and identity confidence.

Evidence Wall

supportingstaleconflict

Human Review Route

Senior reviewer + evidence refresh before draft export.

Evidence Wall

Structured evidence cards show source, type, direction, strength, freshness, and review requirement.

Conflict Board

Contradictions such as ClinVar conflict, stale literature, phenotype mismatch, or transcript/build concern become review actions.

Missing Evidence

Missing segregation, phenotype specificity, or updated literature is converted into recommended reviewer actions.

Safety Boundary

  • No PHI in public sample.
  • No real patient data.
  • No final diagnosis.
  • No final ACMG classification.
  • No treatment recommendation.
  • No clinical release.
  • Human review required.

Built on existing Tynixa layers

This phase reuses existing review package, TraceGraph, safety boundary, human review route, and pilot workspace concepts. New development is limited to the missing Review Room presentation and safe simulator layer.

Open existing review package workspace